No abstract

Citation: Galenko-Yaroshevsky PA, Nefedov DA, Zelenskaya AV, Pavlyuchenko II, Chuyan EN, Ravaeva MY, Tkharkakhova NK (2018) Effects of Dimephosphone on skin survival in conditions of reduced blood circulation. Research Results in Pharmacology 4(4): 41-52. https://doi. AbstractIntroduction: The search for and creation of drugs with dermatoprotective and metabotropic activity is one of the priorities of modern diabetology. Synthetic organophosphorus compounds with no anticholinesterase activity, to which Dimephosphone belongs to, deserve great attention in this respect. Materials and Methods:Experiments included 355 white non-linear male mice (18-34 g) and 799 male rats (150-305 g). The dermatoprotective activity (DPA) of Dimephosphone regarding the survival of a skin graft was studied against the background of normoglycemia, as well as against the background of experimental diabetes complicated by hypercholesterolemia. The study of microhemodynamics in the skin was performed using laser Doppler flowmetry. The effects on metabolic processes and the antioxidant system were studied by determining the levels of glucose, urea, creatinine, total bilirubin, total cholesterol, triglycerides, total protein, albumin, globulin, catalase, malondialdehyde, superoxide dismutase, glutathione reductase, glutathione and glutathione peroxidase.Results: Dimephosphone has a pronounced DPA in conditions of reduced blood circulation against the background of normoglycemia and experimental (alloxan) diabetes complicated by exogenous hypercholesterolemia. By DPA, in most cases against the background of normoglycemia Dimephosphone exceeds Actovegine, is comparable to or inferior to Trental and Mexidol, and is more significant in terms of the therapeutic width than all the drugs taken for comparison.Discussion: According to the obtained data , DPA of Dimephosphone may be due to its ability to exhibit significant vasodilating, antihypoxic, antioxidant, antiaggregant, membrane-stabilizing, anti-acidotic, antimicrobial and other properties and also to exert a normalizing effect on carbohydrate, protein, lipid and energy metabolism Conclusion: Dimephosphone can be recommended for further preclinical and clinical studies in the form of various dosage forms, as well as in a combination therapy for metabolic disorders.

Introduction: The search for and development of new highly active medications and their combinations of the appropriate direction of action remains an urgent problem due to the complications of diabetes mellitus, especially burdened with atherosclerosis, including skin and vascular lesions. Materials and methods: The acute toxicity, histoprotective and dermatoprotective effects of mafusol, rexod, alprostadil and their combinations were studied in male rats with normoglycemia and alloxan diabetes complicated by exogenous hypercholesterolemia. Results: The combination of mafusol with rexod is less toxic than mafusol. In arteriovenous insufficiency of the tail, ischemia of the skin fold and skin flap, mafusol (6.25, 12.5 and 25.0 mg/kg in terms of fumarate), rexod (0.01 and 0.02 mg/kg) and especially their combination (6.25 and 0.01 mg/kg) have significant histoprotective, dermatoprotective, hypoglycemic and lipid-lowering effects, both in normoglycemia and alloxan diabetes complicated by exogenous hypercholesterolemia. Alprostadil (10 mg/kg) and especially its combination with mafusol (6.25 mg/kg) have a dermatoprotective effect. Discussion: Rexod reduces the acute toxicity of mafusol. The dermatoprotective effect of mafusol, rexod and, to a greater extent, their combination may be associated with increased microhemocirculation, antihypoxic properties and activation of energy processes in the skin, normalization of carbohydrate and lipid metabolism in alloxan diabetes, complicated by exogenous hypercholesterolemia, increased reserve capacity of the antioxidant system, and possibly with the ability of mafusol and rexod to reduce blood viscosity and improve rheological properties of the blood. The combination of mafusol with alprostadil increases the dermatoprotective activity of the latter. Conclusion: Combinations of mafusol with rexod and alprostadil can be recommended for clinical study as dermatoprotective agents for treating traumatic injuries and diabetes mellitus complicated by atherosclerosis.

No abstract

1. Gilman A. G., Klinicheskaja farmakologija, Tom 4, 336 (M., Praktika, 2006). 2. Cheretaev I. V., Husainov D. R., Korenjuk I. I., Nejrotropnye, psihotropnye i anal'geticheskie jeffekty salicilatov, ih fiziologicheskie mehanizmy, Molodoj uchenyj, 10, 485 (2015). 3. Grigor'eva A. S., Optimizacija farmakoterapevticheskoj aktivnosti biometallov pri kompleksoobrazovanii s NPVP, Mikrojelementy v medicine, 1, 17, (2000) 4. Bica K., In search of pure liquid salt forms of aspirin: ionic liquid approaches with acetylsalicylic acid and salicylic acid, Phys. Chem. Chem. Phys, 12, 2011 (2010). 5. Chuyan Е. N., Temur'yants N. A., Moskovchuk O. B. Fiziologicheskiye mekhanizmy biologicheskikh effektov nizkointensivnogo EMI KVCH, 448 р. (CHP «El'in'o», Simferopol» 2003). 6. Levyh A. J., Acetilsalicilovaja kislota kak jeffektivnaja i bezopasnaja osnova antiagregantnoj terapii. Arterial'naja gipertenzija, 6 (44), 57 (2015). 7. Kuznecov S. V., Dmitrieva L. E., Sizonov V. A. Serdechnaja, dyhatel'naja i motornaja dejatel'nost' v norme i posle aktivacii katehoaminergicheskih sistem u novorozhdennyh krysjat, Zhurnal jevoljucionnoj biohimii i fiziologii, 48(4), 367 (2012). 8. Ignatyev I. Synthesis and characterization of cobalt (II) complexes with triethanolamine and succinate and/or nitrate anions, J. Transition Metal Chemistry, 43 (2), 127 (2018). 9. Kondratenko J. A. Sintez, stroenie i termicheskoe povedenie kompleksa {Co2[N(CH2CH2OH)3]2Cl2}Cl2, ZhOH, 87 (4), 698, (2017). 10. Sokolik J., Tumova I., Blahova M., Anti-inflammatory activities of copper (II) and zinc (II) 3,6-dimetylsalicylates and their equimolar mixture, Acta Facult. Farm. Univ.comenianae, 53 (1), 224 (2006). 11. Aljohin E. K. Aspirin: novaja zhizn' starogo lekarstva, Sorosovskij obrazovatel'nyj zhurnal, 5(7), 85 (1999). 12. Chohan Z. H., Iqbal M. S., Iqbal H. S. [et al.] Transition metal acetylsalicylates and their anti-inflammatory activity, Journal of enzyme inhibition and medicinal chemistry, 17, 2, 87 (2002). 13. Boer J. L. Mulrooney S. B., Hausinger R. P. Nickel-dependent metalloenzymes, Archives of biochemistry and biophysics, 544, 142 (2014). 14. Christianson D. W. Structural chemistry and biology of manganese metalloenzymes, Progress in biophysics and molecular biology, 67(2-3), 217 (1997). 15. Lindskog S. Cobalt (II) in metalloenzymes, A reporter of structure-function relations. Biochemistry, 153 (Springer, Berlin, Heidelberg. 1970). 16. Mc Call K. A., Huang C., Fierke C. A. Function and mechanism of zinc metalloenzymes, The Journal of nutrition, 130 (5), 1437 (2000).